Bristol-Myers Squibb Company will take part in the Citi 2018 Global Healthcare Conference on Thursday, December 6, 2018 in New York. Tom Lynch, chief scientific officer, will answer questions about the company at 2:10 p.m. ET.
NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Citi 2018 Global Healthcare Conference on Thursday, December 6, 2018 in New York. Tom Lynch, chief scientific officer, will answer questions about the company at 2:10 p.m. ET.
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181129005019/en/
Contacts
Media: Carrie Fernandez, 609-252-5222, carrie.fernandez@bms.com
Investors: Tim Power, 609-252-7509, timothy.power@bms.com or Bill Szablewski,
609-252-5894, william.szablewski@bms.com
Source: Bristol-Myers Squibb Company
View this news release online at:
http://www.businesswire.com/news/home/20181129005019/en
